Bansk Group-Backed Arcadia Consumer Health Acquires Avrio Health
06/05/23, 12:02 PM
Industry
biotechnology
health care
Arcadia Consumer Healthcare ("Arcadia" or the "Company"), a recognized leader and one of the fastest growing platforms in the consumer healthcare market, today announced that it has acquired substantially all of the assets of Avrio Health L.P. ("Avrio"). Arcadia is backed by Bansk Group ("Bansk"), a consumer-focused private investment firm dedicated to building distinctive consumer brands.
Company Info
Company info
Arcadia Consumer Healthcare, formerly known as Kramer Laboratories, is a recognized leader in the consumer healthcare market for over-the-counter medicines and premium vitamins, minerals and supplements. For over 35 years, the company has been delivering innovative healthcare products to help consumers self-treat their everyday problems. Arcadia's flagship brands include Nizoral®, a highly efficacious therapeutic dandruff shampoo brand, NATURELO®, a premium VMS brand derived from 'whole food' ingredients, CloSYS, a science-based oral rinse for sensitive mouths, Kaopectate®, a leader in the treatment of diarrhea and upset stomach, Fungi-Nail®, a specialty anti-fungal product formulated with a clinically proven ingredient that cures and prevents fungal infections, and Opti-NailTM, a unique cosmetic fungal nail repair brand. Additional portfolio brands include HC MaxTM, a maximum strength anti-fungal remedy, and Safetussin®, a pharmacist-developed cough and cold relief solution for adults suffering from diabetes and/or high blood pressure. Arcadia Consumer Healthcare's products are sold in over 60,000 stores nationwide, including major drug, food and mass merchandiser outlets. Learn more at www.arcadiach.com.